Asia-Pacific Dermatology Drug Market Report 2018

February 2018 | 117 pages | ID: AC7D723E3EBEN
QYResearch

Abstracts

In this report, the Asia-Pacific Dermatology Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Dermatology Drug for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Dermatology Drug market competition by top manufacturers/players, with Dermatology Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AbbVie
• Johnson & Johnson
• Bayer
• Galderma
• Bristol-Myers Squibb
• Novartis
• Pfizer
• Merz Pharma
• Valeant
• LEO Pharma
• GlaxoSmithKline

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• External Use
• Oral
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Psoriasis
• Skin Infections
• Acne
• Dermatitis
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Dermatology Drug Market Report 2017

1 DERMATOLOGY DRUG OVERVIEW

1.1 Product Overview and Scope of Dermatology Drug
1.2 Classification of Dermatology Drug by Product Category
  1.2.1 Asia-Pacific Dermatology Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Dermatology Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 External Use
  1.2.4 Oral
  1.2.5 Injection
1.3 Asia-Pacific Dermatology Drug Market by Application/End Users
  1.3.1 Asia-Pacific Dermatology Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Psoriasis
  1.3.3 Skin Infections
  1.3.4 Acne
  1.3.5 Dermatitis
  1.3.6 Other
1.4 Asia-Pacific Dermatology Drug Market by Region
  1.4.1 Asia-Pacific Dermatology Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Dermatology Drug (2012-2022)
  1.5.1 Asia-Pacific Dermatology Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Dermatology Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC DERMATOLOGY DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Dermatology Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Dermatology Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Dermatology Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Dermatology Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Dermatology Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Dermatology Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Dermatology Drug (Volume) by Application
2.4 Asia-Pacific Dermatology Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Dermatology Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Dermatology Drug Revenue and Market Share by Region (2012-2017)

3 CHINA DERMATOLOGY DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Dermatology Drug Sales and Value (2012-2017)
  3.1.1 China Dermatology Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Dermatology Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Dermatology Drug Sales Price Trend (2012-2017)
3.2 China Dermatology Drug Sales Volume and Market Share by Type
3.3 China Dermatology Drug Sales Volume and Market Share by Application

4 JAPAN DERMATOLOGY DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Dermatology Drug Sales and Value (2012-2017)
  4.1.1 Japan Dermatology Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Dermatology Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Dermatology Drug Sales Price Trend (2012-2017)
4.2 Japan Dermatology Drug Sales Volume and Market Share by Type
4.3 Japan Dermatology Drug Sales Volume and Market Share by Application

5 SOUTH KOREA DERMATOLOGY DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Dermatology Drug Sales and Value (2012-2017)
  5.1.1 South Korea Dermatology Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Dermatology Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Dermatology Drug Sales Price Trend (2012-2017)
5.2 South Korea Dermatology Drug Sales Volume and Market Share by Type
5.3 South Korea Dermatology Drug Sales Volume and Market Share by Application

6 TAIWAN DERMATOLOGY DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Dermatology Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Dermatology Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Dermatology Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Dermatology Drug Sales Price Trend (2012-2017)
6.2 Taiwan Dermatology Drug Sales Volume and Market Share by Type
6.3 Taiwan Dermatology Drug Sales Volume and Market Share by Application

7 INDIA DERMATOLOGY DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Dermatology Drug Sales and Value (2012-2017)
  7.1.1 India Dermatology Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Dermatology Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Dermatology Drug Sales Price Trend (2012-2017)
7.2 India Dermatology Drug Sales Volume and Market Share by Type
7.3 India Dermatology Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA DERMATOLOGY DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Dermatology Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Dermatology Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Dermatology Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Dermatology Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Dermatology Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Dermatology Drug Sales Volume and Market Share by Application

9 AUSTRALIA DERMATOLOGY DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Dermatology Drug Sales and Value (2012-2017)
  9.1.1 Australia Dermatology Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Dermatology Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Dermatology Drug Sales Price Trend (2012-2017)
9.2 Australia Dermatology Drug Sales Volume and Market Share by Type
9.3 Australia Dermatology Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC DERMATOLOGY DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 AbbVie
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Dermatology Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AbbVie Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Dermatology Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Johnson & Johnson Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Bayer
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Dermatology Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Bayer Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Galderma
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Dermatology Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Galderma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Bristol-Myers Squibb
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Dermatology Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Novartis
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Dermatology Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Novartis Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Pfizer
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Dermatology Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Pfizer Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Merz Pharma
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Dermatology Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Merz Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Valeant
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Dermatology Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Valeant Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 LEO Pharma
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Dermatology Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 LEO Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 GlaxoSmithKline

11 DERMATOLOGY DRUG MANUFACTURING COST ANALYSIS

11.1 Dermatology Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Dermatology Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Dermatology Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Dermatology Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC DERMATOLOGY DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Dermatology Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Dermatology Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Dermatology Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Dermatology Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Dermatology Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Dermatology Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Dermatology Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Dermatology Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Dermatology Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Dermatology Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Dermatology Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Dermatology Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Dermatology Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Dermatology Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Dermatology Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Dermatology Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Dermatology Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Dermatology Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Dermatology Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Dermatology Drug
Figure Asia-Pacific Dermatology Drug Sales Volume (MT) by Type (2012-2022)
Figure Asia-Pacific Dermatology Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure External Use Product Picture
Figure Oral Product Picture
Figure Injection Product Picture
Figure Asia-Pacific Dermatology Drug Sales (MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Dermatology Drug by Application in 2016
Figure Psoriasis Examples
Table Key Downstream Customer in Psoriasis
Figure Skin Infections Examples
Table Key Downstream Customer in Skin Infections
Figure Acne Examples
Table Key Downstream Customer in Acne
Figure Dermatitis Examples
Table Key Downstream Customer in Dermatitis
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Dermatology Drug Market Size (Million USD) by Region (2012-2022)
Figure China Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Dermatology Drug Sales Volume (MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Dermatology Drug Market Major Players Product Sales Volume (MT)(2012-2017)
Table Asia-Pacific Dermatology Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Dermatology Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Dermatology Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Dermatology Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Dermatology Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Dermatology Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Dermatology Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Dermatology Drug Revenue Share by Players
Figure 2017 Asia-Pacific Dermatology Drug Revenue Share by Players
Table Asia-Pacific Dermatology Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Dermatology Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Dermatology Drug by Type (2012-2017)
Figure Asia-Pacific Dermatology Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Dermatology Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Dermatology Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dermatology Drug by Type (2012-2017)
Figure Asia-Pacific Dermatology Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Dermatology Drug Sales Volume (MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Dermatology Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Dermatology Drug by Region (2012-2017)
Figure Asia-Pacific Dermatology Drug Sales Market Share by Region in 2016
Table Asia-Pacific Dermatology Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Dermatology Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Dermatology Drug by Region (2012-2017)
Figure Asia-Pacific Dermatology Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Dermatology Drug Sales Volume (MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Dermatology Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Dermatology Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Dermatology Drug Sales Market Share by Application (2012-2017)
Figure China Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure China Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Dermatology Drug Sales Price (USD/Kg) Trend (2012-2017)
Table China Dermatology Drug Sales Volume (MT) by Type (2012-2017)
Table China Dermatology Drug Sales Volume Market Share by Type (2012-2017)
Figure China Dermatology Drug Sales Volume Market Share by Type in 2016
Table China Dermatology Drug Sales Volume (MT) by Applications (2012-2017)
Table China Dermatology Drug Sales Volume Market Share by Application (2012-2017)
Figure China Dermatology Drug Sales Volume Market Share by Application in 2016
Figure Japan Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Japan Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Dermatology Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Dermatology Drug Sales Volume (MT) by Type (2012-2017)
Table Japan Dermatology Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Dermatology Drug Sales Volume Market Share by Type in 2016
Table Japan Dermatology Drug Sales Volume (MT) by Applications (2012-2017)
Table Japan Dermatology Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Dermatology Drug Sales Volume Market Share by Application in 2016
Figure South Korea Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure South Korea Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Dermatology Drug Sales Price (USD/Kg) Trend (2012-2017)
Table South Korea Dermatology Drug Sales Volume (MT) by Type (2012-2017)
Table South Korea Dermatology Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Dermatology Drug Sales Volume Market Share by Type in 2016
Table South Korea Dermatology Drug Sales Volume (MT) by Applications (2012-2017)
Table South Korea Dermatology Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Dermatology Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Taiwan Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Dermatology Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Taiwan Dermatology Drug Sales Volume (MT) by Type (2012-2017)
Table Taiwan Dermatology Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Dermatology Drug Sales Volume Market Share by Type in 2016
Table Taiwan Dermatology Drug Sales Volume (MT) by Applications (2012-2017)
Table Taiwan Dermatology Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Dermatology Drug Sales Volume Market Share by Application in 2016
Figure India Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure India Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Dermatology Drug Sales Price (USD/Kg) Trend (2012-2017)
Table India Dermatology Drug Sales Volume (MT) by Type (2012-2017)
Table India Dermatology Drug Sales Volume Market Share by Type (2012-2017)
Figure India Dermatology Drug Sales Volume Market Share by Type in 2016
Table India Dermatology Drug Sales Volume (MT) by Application (2012-2017)
Table India Dermatology Drug Sales Volume Market Share by Application (2012-2017)
Figure India Dermatology Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Dermatology Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Dermatology Drug Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Dermatology Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Dermatology Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Dermatology Drug Sales Volume (MT) by Applications (2012-2017)
Table Southeast Asia Dermatology Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Dermatology Drug Sales Volume Market Share by Application in 2016
Figure Australia Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Australia Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Dermatology Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Australia Dermatology Drug Sales Volume (MT) by Type (2012-2017)
Table Australia Dermatology Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Dermatology Drug Sales Volume Market Share by Type in 2016
Table Australia Dermatology Drug Sales Volume (MT) by Applications (2012-2017)
Table Australia Dermatology Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Dermatology Drug Sales Volume Market Share by Application in 2016
Table AbbVie Dermatology Drug Basic Information List
Table AbbVie Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure AbbVie Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure AbbVie Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Dermatology Drug Basic Information List
Table Johnson & Johnson Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer Dermatology Drug Basic Information List
Table Bayer Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Bayer Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Galderma Dermatology Drug Basic Information List
Table Galderma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Galderma Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Galderma Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Galderma Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol-Myers Squibb Dermatology Drug Basic Information List
Table Bristol-Myers Squibb Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Dermatology Drug Basic Information List
Table Novartis Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Novartis Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Dermatology Drug Basic Information List
Table Pfizer Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Merz Pharma Dermatology Drug Basic Information List
Table Merz Pharma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merz Pharma Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Merz Pharma Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Merz Pharma Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Valeant Dermatology Drug Basic Information List
Table Valeant Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Valeant Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure Valeant Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Valeant Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table LEO Pharma Dermatology Drug Basic Information List
Table LEO Pharma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure LEO Pharma Dermatology Drug Sales (MT) and Growth Rate (2012-2017)
Figure LEO Pharma Dermatology Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure LEO Pharma Dermatology Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Dermatology Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Kg) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatology Drug
Figure Manufacturing Process Analysis of Dermatology Drug
Figure Dermatology Drug Industrial Chain Analysis
Table Raw Materials Sources of Dermatology Drug Major Manufacturers in 2016
Table Major Buyers of Dermatology Drug
Table Distributors/Traders List
Figure Asia-Pacific Dermatology Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Dermatology Drug Price (USD/Kg) and Trend Forecast (2017-2022)
Table Asia-Pacific Dermatology Drug Sales Volume (MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Dermatology Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Dermatology Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Dermatology Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Dermatology Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Dermatology Drug Revenue Market Share Forecast by Region in 2022
Figure China Dermatology Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure China Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Dermatology Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Dermatology Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Dermatology Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Dermatology Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure India Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Dermatology Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Dermatology Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Australia Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Dermatology Drug Sales (MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Dermatology Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Dermatology Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Dermatology Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Dermatology Drug Price (USD/Kg) Forecast by Type (2017-2022)
Table Asia-Pacific Dermatology Drug Sales (MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Dermatology Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources